SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:57 pm Purchase | 2024-09-30 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 4,328,904 9.990% | 1,644,899 (+61.29%) | Filing |
| 2024-02-13 5:19 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 2,684,005 7.800% | 887,626 (+49.41%) | Filing |
| 2023-03-10 5:15 pm Purchase | 2023-01-25 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,796,379 5.300% | 724,077 (+67.53%) | Filing |
| 2023-02-13 10:51 am Sale | 2022-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,072,302 3.100% | -673,998 (-38.60%) | Filing |
| 2022-02-11 5:03 pm Purchase | 2021-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,746,300 7.100% | 449,848 (+34.70%) | Filing |
| 2021-09-17 4:54 pm Purchase | 2021-09-07 | 13G | KalVista Pharmaceuticals, Inc. KALV | SUVRETTA CAPITAL MANAGEMENT, LLC | 1,296,452 5.300% | 1,296,452 (New Position) | Filing |